Anna Richards-Migdalska
Rowland Hill Street
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
An Overview of Epigenetic Changes in the Parkinson's Disease Brain.
Journal: International journal of molecular sciences
Published: May 05, 2024
DNA Methylation of α-Synuclein Intron 1 Is Significantly Decreased in the Frontal Cortex of Parkinson's Individuals with GBA1 Mutations.
Journal: International journal of molecular sciences
Published: October 04, 2022
L444P Gba1 mutation increases formation and spread of α-synuclein deposits in mice injected with mouse α-synuclein pre-formed fibrils.
Journal: PloS one
Published: May 13, 2020
Effects of ambroxol on the autophagy-lysosome pathway and mitochondria in primary cortical neurons.
Journal: Scientific reports
Published: July 24, 2017
The L444P Gba1 mutation enhances alpha-synuclein induced loss of nigral dopaminergic neurons in mice.
Journal: Brain : a journal of neurology
Published: April 28, 2017
Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate.
Journal: Synapse (New York, N.Y.)
Published: November 17, 2016
Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice.
Journal: Annals of neurology
Published: July 20, 2016
Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease.
Journal: Human molecular genetics
Published: February 26, 2016
The relationship between glucocerebrosidase mutations and Parkinson disease.
Journal: Journal of neurochemistry
Published: May 26, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026